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Abstract
Background: As a negative modulator of the canonical Wnt signaling pathway, Naked1 (NKD1) is widely expressed
in many normal tissues. However, the expression pattern and clinicopathological significance of NKD1 in patients
with non-small-cell lung cancer (NSCLC) is still unclear.
Methods: Immunohistochemical studies were performed on 35 cases of normal lung tissues and 100 cases of
NSCLC, including 66 cases with complete follow-up records. The NKD1 protein and mRNA expressions were
detected by western blot and Real-time PCR, respectively. To examine the effect of NKD1 on the invasiveness of
lung cancer cells, NKD1 was down-regulated by siRNA in lung cancer cell lines and the invasive ability was then
evaluated by the Matrigel invasion assay. In addition, the expressions of Dishevelled-1 and b-catenin proteins, as
well as MMP mRNA were also examined in NKD1 knockdown cells.
Results: In 35 fresh lung cancer tissues examined, 27(79%) of them exhibited lower levels of NKD1 protein in
comparison with their corresponding normal tissue (P = 0.009). However, the NKD1 mRNA level was significantly
higher in cancerous lung tissues, compared with the adjacent normal tissues. In 100 NSCLC tissues, NKD1 was
significantly lower in 78 cases (78%) than in the normal specimens, determined by immunohistochemical staining.
The reduced NKD1 expression was correlated with histological type (P = 0.003), poor differentiation (P = 0.004),
lymph node metastasis (P = 0.013), TNM stage (P = 0.002) and poor survival (62.88 ± 3.23 versus 23.61 ± 2.18
months, P = 0.03). In addition, NKD1 knockdown could up-regulate Dishevelled-1 and b-catenin protein levels, as
well as increased MMP-7 transcription and the invasive ability of lung cancer cells. Furthermore, when the NKD1-
knockdown cells were treated with Dishevelled-1 antibody, their invasive potential was significantly reduced.
Conclusion: NKD1 protein is reduced but NKD1 mRNA is elevated in NSCLC. Reduced NKD1 protein expression
correlates with a poor prognosis in NSCLC. NKD1 might inhibit the activity of the canonical Wnt pathway through
Dishevelled-1.
Background
dNKD (Naked Cuticle Drosophila) was first found in
Drosophila and mutation of the Naked gene could induce
the loss of segmentation of Drosophila [1]. Subsequently,
NKD1 and NKD2, two homologues of drosophila naked
cuticle, were also detected in mammalians [2]. These two
genes are located on chromosome 16q12.1 and 5p15.3,
respectively, in human beings, and share 43.8% amino-
acid sequence homology. NKD1 has been proposed to
interact with Dishevelled (Dvl) through its conservative
domain which forms an EF-hand-like motif, functioning
as a negative regulator of the canonical Wnt/b-catenin
signaling pathway [3-6]. Dishevelled (Dvl) is a positive
regulatory factor located upstream of the Wnt pathway,
and plays a role in regulating at least two intracellular
Wnt signal pathways, such as the canonical Wnt/b-cate-
nin pathway and JNK/PCP pathway [7].
NKD1 is an antagonist of the canonical Wnt/b-catenin
pathway. When it directly interacts with PDZ domain of
Dishevelled (Dvl) in the cytoplasm, the canonical Wnt/
b-catenin signaling pathway is inhibited. It has been
demonstrated that NKD1 could act as a switch that
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and away from the canonical Wnt/b-catenin pathway,
thus inhibiting the canonical Wnt pathway.
Although there are increasing reports of NKD1 today,
the role of NKD1 in cancer progression still needs to be
further addressed. It has been reported that the NKD1
mRNA level was up-regulated in colorectal adenomas
[8] and hepatoblastoma [9]. Conversely, NKD1 protein
expression was down-regulated in some gastric cancer
tissues. This raises a question of whether the expression
level of NKD1 protein is parallel to the mRNA level in
the same tumor type. Moreover, to the best of our
knowledge, the relationship between NKD1 expression
and clinicopathological features in human tumor has
not been reported in the English literature.
In the current study, we examine the expression of
NKD1 in 100 cases of non-small-cell lung cancer
(NSCLC) and correlate it with corresponding clinico-
pathological factors, including histologic type, neoplastic
differentiation, lymph node metastasis and clinical out-
come. In addition, we ablated NKD1 by siRNA technol-
ogy in lung cancer cell lines to investigate alterations in
Dishevelled-1 and b-catenin protein levels, MMP-7 tran-
scription and the invasive ability of NKD1-knockdown
lung cancer cells, to provide insight into the role of
NDK1 in the biological behavior of lung cancers.
Methods
Patient and Samples
Paraffin specimens (n = 100) were obtained from
patients with lung cancer at the First Affiliated Hospital
of China Medical University. Complete follow-up infor-
mation of 66 patients (30 cases of adenocarcinoma and
36 cases of squamous cell carcinoma) was obtained
from review of the patients’ medical records. None of
these patients had received chemotherapy or radiother-
apy before surgical resection. The mean age of these
patients was 58 years. According to the WHO histologi-
cal classification criteria [10], there were 33 cases of
squamous cell carcinoma (SCC) and 67 cases of adeno-
carcinoma (ADC). The p-TNM staging system of the
International Union Against Cancer in 2009 [11] was
used to classify cases as stages I (n = 24), II (n = 20), III
(n = 44), and IV (n = 12).
In addition, 35 paired tissue samples of tumor and
parallel non-tumor portion (with >5 cm distance from
the primary tumor’s edge) for the same case were
quickly frozen in liquid nitrogen and stored at -70°C for
mRNA and protein analyses.
Immunohistochemistry
As described previously [12-14], the tissues were fixed
with 10% neutral formalin, embedded in paraffin, and 4-
μm-thick sections were prepared. All the sections were
stained by the streptavidin-peroxidase (S-P) method.
Briefly, the sections were incubated with NKD1 polyclo-
nal antibody (1:100, Santa Cruz Biotechnology, Inc.) at
4°C overnight. Meanwhile negative control samples were
incubated with non-immune rabbit IgG at the same
dilution as for the primary antibody. Biotinylated sec-
ondary antibody and diaminobenzidine (DAB) were pur-
chased from Maixin Biotechnology (Fuzhou, China).
Evaluation of Immunostaining
Five random 200× microscopic fields were examined per
slide, and 100 cells were evaluated per field. The expres-
sion of NKD1 was classified into five groups according
to the percentage of positively staining cells: 0 = absent;
1 = 1-25%; 2 = 26-50%; 3 = 51-75%; 4 = ≥76%. The
staining intensity was categorized as follows: 0 = nega-
tive; 1 = weak; 2 = moderate; and 3 = strong. The pro-
portion and intensity scores were then multiplied to
obtain a total score.
Since the scores in all 35 cases of normal lung tissues
were all ≥ 3, we regarded the scores less than 3 as
“reduced expression”, while scores of 3 or more were
considered as “normal expression”.
RT- PCR and Real-Time PCR
Total RNA was extracted with Trizol regent (Invitrogen)
according to the manufacturer’si n s t r u c t i o n s .R T - P C R
for MMP-7 mRNA was performed with the AMV
Ver3.0 kit (Takara, Shiga, Japan). PCR was carried out
with the following primers (Table 1). The relative
mRNA levels were normalized by the relative amount of
b-actin mRNA. Real-Time PCR experimentation for
Naked1 mRNA was carried out as follows: Primers were
designed and synthesized by Takara Biotechnology
(Dalian, China). Reverse transcription of 1 μgR N Aw a s
performed with the RT kit (Applied Biosystems, Foster
City, CA, USA) and quantitative Real-Time PCR was
done using SYBR Green PCR master mix (Applied
Table 1 Primers sequences and reaction condition
Primer Length Temperature Cycle
MMP-7 F: 5’-AGATCCCCCTGCATTTCAGG-3’ 163 bp 61°C 35
R: 5’-TCGAAGTGAGCATCTCCTCC-3’
b-Actin F: 5’-AGAGCTCAGAGCTGCCTGAC-3’ 308 bp 55°C 25
R: 5’-AGTACTTGCGCTCAGGAGGA-3’
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fast Real-Time PCR system (Applied Biosystems) as fol-
lows: 95°C for 30 s, 40 cycles of 95°Cfor 5 s, and 60°C
for 30 s. The sequences of the primer pairs were as fol-
lows: NKD1 forward, 5
,-TCGCCGGGATAGAAAAC-
TACA-3
,, reverse, 5
,-CAGTTCTGACTTCTGGGCCAC-
3
,; b-actin forward, 5
,-ATAGCACAGCCTGGATAG-
CAACGTAC-3
,, reverse, 5
,-CACCTTCTACAATGAG-
CTGCGTGTG-3
,.
A dissociation procedure was performed to generate a
melting curve for confirmation of amplification specifi-
city. b-actin mRNA was quantified in parallel as the
reference control. Relative gene expression was calcu-
lated using the Stratagene MxPro software.
Western Blot
As described previously, total protein was extracted with
RIPA lysis buffer and quantified using the Bradford
method. Protein lysates (100 μg) were separated by 10%
SDS-PAGE and transferred to the polyvinylidene fluor-
ide (PVDF) membranes. After blocking, the blots were
incubated with primary antibodies directly against
NKD1 Ⅰ(1:200, Santa Cruz), NKD1 Ⅱ (1:500, Cell Signal-
ing) and b-catenin (1:800) at 4°C overnight. After that,
the blots were incubated with the secondary antibody
labeled with HRP at room temperature for 2 h. Protein
bands were visualized using enhanced chemilumines-
cence (ECL) and detected using the BioImaging System.
The relative protein levels were calculated by compari-
son to the amount of b-actin protein. The experiments
were repeated three times independently.
Cell Culture and Transfection
HBE (the normal human bronchial epithelial cell lines)
were obtained from the Cell Bank of Chinese Academy
of Science (Shanghai, China). The lung carcinoma cell
lines, BE1 and LH7 were kindly provided by Professor
Jie Zheng (College of Medicine, Peking University,
China). BE1 and LH7 cell lines are two subclones of
lung giant cell carcinoma and the BE1 cell line has a
high metastatic potential compared with LH7. The b-
catenin protein of these two cell lines were both higher
than HBE [15]. The Human lung squamous cell line LK
and adenocarcinoma cell line LTEP-a-2 (hereafter
referred to as LTEP) were purchased from the American
Type Culture Collection (Manassas, VA, USA). The cells
were cultured in RPMI-1640 (GIBCO, Inc, Grand Island,
NY) containing 10% fetal calf serum (Invitrogen), 100 IU
⁄mL penicillin (Sigma, St. Louis, MO, USA), and 100 μg ⁄
mL streptomycin (Sigma) in a humidified atmosphere
with 5% CO2.
NKD1 siRNA (SC-93414) and negative control siRNA
(Cat. SC-36869) were all purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). For transient
transfection, the cells were cultured in a 24-well plate
24 h before the experiment. Then the cells were trans-
fected with Lipofectamine 2000 (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions. Fol-
lowing the transfection, the cells were harvested at 48
hours to measure the mRNA and protein levels.
Matrigel Invasion Assay
The cells’ invasive abilities were examined using a 24-
well Transwell with 8-μm pore polycarbonate membrane
inserts (Corning Inc., Corning, NY, USA) according to
the manufacturer’s protocol. Cells that appeared on the
lower surface of the filter were counted in five random
×200 fields using an inverted microscope (Olympus
IX51; Olympus America Inc, Melville, NY, USA). The
experiments were performed in triplicate and got means
were calculated.
Statistical analysis
SPSS version 13.0 for Windows was used for all ana-
lyses. The chi-square test was used to examine possible
correlations between NKD1 expression and clinico-
pathological factors. The Student’s t -test was used to
analyze the results of RT-PCR and western blotting. The
Kaplan-Meier method was used for survival analysis,
which was measured from the day of surgical resection
until death from any cause. The Cox’s proportional
hazard regression model was used to estimate the possi-
ble prognostic significance of clinicopathological vari-
ables. P < 0.05 was considered to indicate statistical
significance.
Results
The protein expression of NKD1 in NSCLC is lower, while
mRNA expression is higher than that in normal lung
tissue
Total protein of 35 paired NSCLC tissues and adjacent
noncancerous lung tissues were extracted and the pro-
tein expression of NKD1 was detected by Western blot.
The results showed that the expression of NKD1 protein
in NSCLC is lower than that in normal lung tissue (P <
0.05, Figure 1A and addition file 1, Figure S1A).
To further examine the expression of NKD1 in cell
lines, two lung cancer cell lines (BE1 and LH7) were
chosen in our study. HBE, a normal human bronchial
epithelial cell line, was used as a control. The results
showed that the NKD1 protein expression in HBE was
higher than in the lung cancer cell lines. Moreover,
NKD1 expression in BE1 cells (high metastatic poten-
tial) was lower than that in LH7 cells (low metastatic
potential) (Figure 1B and addition file, Figure S1B).
The above results implied that NKD1 expression
might be associated with invasiveness of lung cancer
cells. However, Real-time PCR results showed that
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comparison with corresponding normal lung tissues
(Figure 2A). The same results also can be found in cell
lines (Figure 2B).
Reduced NKD1 protein expression was associated with
clinicopathological factors and poor prognosis of NSCLC
In 35 cases of normal lung tissues examined by immuno-
histochemistry, NKD1 was mainly expressed in the cyto-
plasm of bronchial epithelial cells (≥3 score According to
our evaluation criteria, they were categorized as normal
expression (Figure 3A). In contrast, in the 100 NSCLC
specimens, expression of NKD1 was reduced (<3 score)
in 78 (78%) samples and was normal (≥3s c o r e )i n2 2
(22%) samples (Figure 3B and 3C) (Table 2).
We then analyzed the relationship between NKD1
protein expression and clinicopathological factors in 100
NSCLC samples. The rate of normal NKD1 expression
in squamous carcinoma (13/33, 39.4%) was higher than
that in adenocarcinoma (9/67, 13.4%) (P = 0.003); the
rate of normal NKD1 in stages I-II (16/44, 36.3%) was
higher than in stages III-IV (6/56, 10.7%) (P = 0.002);
and the rate was also higher in cases without lymphatic
metastasis (15/45, 33.3%) than in cases with lymphatic
metastasis (7/55, 12.7%) (P = 0.013). In addition, the
expression rate of NKD1 in NSCLC with well-moderate
differentiation (17/50, 34%) was higher than in the
group with poor histologic differentiation (5/50, 10%)
(P = 0.004). There was no significant correlation
between NKD1 protein expression and gender or age
(P > 0.05, Table 2).
As shown in Figure 4, Kaplan-Meier survival showed
that the mean overall survival in the patients with nor-
mal level of NKD1 protein was significantly longer than
that in the patients with a low level of NKD1 (62.88 ±
3.23 versus 23.61 ± 2.18 months) ( P = 0.03, Figure 4).
In order to clarify if the reduced NKD1 expression
was associated with patients’ prognoses, we employed
the Cox’s proportional hazard regression model, and the
result showed that reduced expression of NKD1 protein
w a sah a z a r df a c t o rf o rt h ep r o g n o s i so fp a t i e n t sw i t h
NSCLC (Hazard Ratio = 1.864, with 95% confidence
interval = 1.143~2.975; P = 0.017, Table 3).
NKD1 depletion could up-regulate Dishevelled-1, b-
Catenin protein expression and enhance the invasive
ability of lung cancer cells
After transfection of siRNA-NKD1, the NKD1 protein
expression was down-regulated approximately 60% in
comparison with control cells (P < 0.05). Correspondingly,
the protein expressions of Dishevelled-1 and b-catenin
were apparently up-regulated (Figure 5A and 5B).
In order to examine the effect of NKD1 on the inva-
siveness of lung cancer cells, we down-regulated NKD1
expression in the LTEP and LK cell lines and evaluated
the change of their invasive abilities by the Matrigel
Figure 1 Expression of NKD1 in lung cancer tissues and cell
lines. (A). Compared with normal lung tissue (N1-N3), NKD1 protein
expression was significantly decreased in lung cancer tissues (T1-T3)
(P < 0.05). (B). NKD1 protein expression in BE1 and LH7 cells was
lower than that in HBE cells, a normal human bronchial epithelial
cell line (P < 0.05). In addition, NKD1 protein expression in BE1 cells
(high metastatic potential) was lower than that in LH7 cells (low
metastatic potential) (P < 0.05).
Figure 2 Real time PCR analyses of NKD1 mRNA in lung cancer tissues and cell lines. (A). The NKD1 mRNA expression in the lung cancer
tissues was significantly higher than in corresponding non-tumorous tissues. (B). NKD1 mRNA expression in BE1 and LH7 cells was higher than
that in HBE cells. NKD1 mRNA expression in BE1 cells (high metastatic potential) was higher than in LH7 cells (low metastatic potential).
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ities of the LTEP and LK cells were significantly
enhanced when NKD1 was down-regulated by siRNA.
When the NKD1-depleted cells were treated with Dvl-1
specific antibody (200 ng/ml), which was used to block
Dvl-1 function, the invasive ability of the NKD1-
depletion cells was significantly reduced (P < 0.05, Fig-
ure 6A and 6B).
These results demonstrated that NKD1 down-regula-
tion could up-regulate Dvl-1, b-catenin protein expres-
sion and enhance the invasive ability of lung cancer
cells. Since Dvl-1 and b-catenin function as positive
Figure 3 Immunohistochemical staining of NKD1 in NSCLC. NKD1 was expressed in the cytoplasm of normal bronchial epithelial cells
(Normal expression) (A). NKD1 expression was significantly decreased in lung squamous cell carcinoma (B) and adenocarcinoma (C) (Reduced
expression). Negative controls were prepared by non-immune rabbit IgG at the same dilution as for the primary antibody in normal (D) and
tumor sample (E and F).
Table 2 Relationship between NKD1expression and the clinicopathological factors in patients with NSCLC
Clinicopathological factors n Normal expression Reduced expression X
2 P-value
Age(yr)
<58 55 13 42 0.191 0.662
≥58 45 9 36
Gender
Male 63 15 48 0.325 0.569
Female 37 7 30
Histology
SCC 33 13 20 8.684 0.003
AC 67 9 58
Differentiation
Well to moderate 50 17 33 8.392 0.004
Poor 50 5 45
pTNM staging
I-II 44 16 28 9.447 0.002
III-IV 56 6 50
Lymph node metastasis
No 45 15 30 6.124 0.013
Yes 55 7 48
SCC, squamous cell carcinoma; AC, Adenocarcinoma; pTNM staging, pathological TNM staging.
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plausible that NKD1 may increase the invasive ability of
lung cancer cells through activating the canonical Wnt
pathway. To test this hypothesis, we examined the
expression of MMP-7(a target gene of the canonical
Wnt pathway) in NKD1-depleted cells and found that
MMP-7 mRNA levels were significantly increased in
comparison with lung cancer cells without NKD1 deple-
tion (P < 0.05, Figure 7A and 7B).
Discussion
NKD1, a negative regulator of the canonical Wnt signal-
ing pathway, is widely expressed in many normal tissues.
It has been demonstrated that NKD1 protein was down-
regulated in gastric cancer, whereas its mRNA expres-
sion was up-regulated in colorectal adenomas and
hepatoblastoma. However, it is currently unclear
whether or not NKD1 protein expression is in parallel
to the mRNA expression in the same individual tumor.
In addition, the relationship between NKD1 and clinico-
pathological factors needs to be further clarified. In
order to provide insight into these clinicopathological
aspects, we used paired NSCLC/normal tissues and lung
cancer cell lines to investigate the NKD1 expression at
both mRNA and protein levels, and correlated the data
from NSCLC tissues with pathologic and clinical find-
ings in the individual patients.
The NKD1 protein expression in NSCLC tissues was
lower than that in normal lung tissue in our study. The-
oretically, this would result in activating the canonical
Wnt pathway by losing NKD1’s negative regulatory
effect in the pathway. Our immunohistochemical results
demonstrated that reduced NKD1 expression was asso-
ciated with poor differentiation, high pTNM stage,
lymph node metastasis and poor prognosis in NSCLC.
This interpretation is in keeping with the results
obtained from our in vitro experiments on BE1 and
LH7 cells, which were two sub-clones derived from a
single lung cancer cell line. The BE1 cells which have
demonstrated high metastatic potential showed much
l o w e rl e v e l so fN K D 1t h a nt h eL H 7c e l l st h a th a v el o w
metastasis. Furthermore, our NKD1 knockdown assays
using the siRNA technology revealed an enhanced inva-
sive ability in LTEP and LK cells, supporting the notion
that loss of NKD1 activity might critically contribute to
the metastatic potential in lung cancer cells.
In order to explore how NKD1 knockdown increases
the invasive ability of lung cancer cells, we measured
the protein expressions of Dvl-1, Dvl-3 and b-catenin,
the key protein factors involved in the Wnt pathway,
as well as the transcriptional expression of MMP-7,
the down-stream gene of Wnt pathway [16-18], in
NKD1 down-regulated cells. The results showed that
NKD1 knockdown caused dramatically up-regulated
protein expression of two positive modulators of the
canonical Wnt pathway, Dvl-1 and b-catenin as well as
enhanced transcription of the MMP-7 gene. These
data suggested that NKD1 knockdown could activated
the Wnt pathway in LTEP and LK cell lines. Recently,
Yan D et al demonstrated that NKD1 could up-regu-
late b-catenin protein expression in human colon
tumors, and Hu T et al reported NKD2, a homologue
of NKD1, could accelerate the degradation of Dishev-
elled by increasing its polyubiquitylation [19].
A l t h o u g ho u rd a t aa r es i m i l a rt ot h o s eb e i n gr e p o r t e d ,
whether the same mechanism is involved in modula-
tion of Dishevelled by NKD1 and NKD2 remains to be
further studied.
Figure 4 Relationship between Naked1 expression in NSCLC
and postoperative survival period of NSCLC patients. The
Kaplan-Meier curve shows that the overall survival in the patients
with lower expression of Naked1 is significantly shorter than in the
group with normal expression (p = 0.03).
Table 3 Cox regression model for prediction of 100
patients with lung cancer
95%CI
Factor P-value Hazard Ratio Lower Upper
Age 0.081 0.612 0.332 1.064
Gender 0.276 1.013 0.726 1.998
Histology 0.037 0.912 0.665 1.631
Differentiation 0.025 0.600 0.354 1.072
pTNM staging 0.014 1.554 1.002 2.439
Lymph node metastasis 0.002 1.421 1.265 1.726
Reduced NKD1 expression 0.017 1.864 1.143 2.975
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specific antibody, NKD1 knockdown LTEP and LK cells
were shown to have an increased transcription of MMP-
7 and an enhanced invasive ability. The result further
indicated that NKD1 might play a role as a negative reg-
ulator of the canonical Wnt signaling pathway in these
two lung cancer cell lines. Moreover, we found that
NKD1 knockdown markedly up-regulated Dvl-1 protein
expression but did not significantly change Dvl-3 pro-
tein expression. We have previously demonstrated that
Dvl-1 mainly involved the canonical Wnt pathway, while
Dvl-3 primarily regulated the activity of non-canonical
Wnt pathway in lung cancer cells [20]; thereby, expres-
sion of MMP-7 was chosen as a marker to reflect the
activity of the classical Wnt signal pathway in our study.
Interestingly, the NKD1 protein expression in NSCLC
is lower than in normal lung tissue, whereas the mRNA
expression in NSCLC is higher than in normal lung tis-
sue. These data were consistent with the previous
reports, and demonstrated that NKD1 protein expres-
sion was dissociated with its mRNA expression at least
in NSCLC. We speculate the enhanced NKD1 mRNA
level might be due to the elevated activity of Wnt path-
way in NSCLC, given that the NKD1 gene is one of the
target genes down-stream of the classical Wnt pathway.
This is a probable feed-back mechanism. In NSCLC,
this feed-back loop is formed by a decrease inNKD1
protein ® increase in b-catenin protein ® activation of
Wnt pathway®up-regulation of NKD1 mRNA tran-
scription. However, this feed-back loop seems to be
incomplete, given the enigmatic low level of NKD1 pro-
tein despite a high level of mRNA. Previous study on
both colorectal carcinomas and hepatoblastomas has
suggested that up-regulation of NKD1 mRNA could be
a marker of activation of the Wnt signaling pathway in
those tumors; while this up-regulation seemed to corre-
late with b-catenin mutational status in colon cancer, it
was generalized in hepatoblastomas. Moreover, we have
previously demonstrated that there was no b-catenin
mutation in NSCLC [21], and when NKD1 was knocked
down in LK and LTEP cell lines, b-catenin protein was
up-regulated. This suggested that the up-regulation of
b-catenin protein in NSCLC was not due to the muta-
tion of b-catenin, but may be related to the down
Figure 5 Knockdown of NKD1 could up-regulate Dishevelled-1 and b-catenin expression in lung cancer cells. NKD1 knockdown resulted
in a significantly reduced expression of NKD1 in LTEP (A) and LK (B) cells. Meanwhile, Dishevelled-1 and b-catenin protein expression was
dramatically up-regulated (P < 0.05). Note that Dishevelled-3 expression showed no change in NKD1 knockdown cells (P > 0.05).
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mechanism in which NKD1 regulates the expression of
b-catenin in NSCLC remains to be further investigated.
How NKD1 protein expression was reduced in
NSCLC with up-regulated NKD1 mRNA is an essential
question to be clarified. The mechanisms may involve a
post-translation modification of NKD1, and/or the pro-
cess of protein degradation. Theoretically, as a negative-
feedback loop exists to control the level of NKD1 pro-
tein, the high expression of NKD1 protein might inhibit
the classical Wnt signal pathway and thereby inhibit the
transcription of NKD1 [22]. Conversely, reduced NKD1
protein might enhance the activity of the classical Wnt
pathway and up-regulate the transcription and transla-
tion of NKD1 gene, thus promoting the NKD1 protein
expression. However, this final step of the feed-back bal-
ancing mechanism might be disrupted in cancer cells.
The NKD1 protein degradation might be accelerated or
t h ep r o t e i nm i g h tb em o r ef r a g i l ed u et ot h ea l t e r e d
post-translation modifications of the protein. Thereby,
the NKD1 protein tends to beat a low level in lung
cancer cells, even though the classical Wnt pathway is
constantly shown to be activated. Certainly, more
experimental studies are needed to test our hypothesis.
Conclusion
We found that NKD1 protein was down-regulated in
lung cancer tissues, which was associated with poor dif-
ferentiation, high pTNM stage, lymph node metastasis
and poor prognosis of NSCLC. Interestingly, NKD1 pro-
tein in NSCLC was lower than that in normal lung tissue,
whereas the mRNA expression in NSCLC is higher than
that in normal lung tissue. In addition, NKD1 knock-
down by siRNA technology could markedly up-regulate
Dishevelled-1 and b-catenin protein levels, enhance the
transcription of MMP-7 and promote the invasiveness of
lung cancer cells. Furthermore, when the NKD1-knock-
down cells were treated with Dishevelled-1 antibody,
their invasive ability was significantly reduced. Our data
support the nation that the decreased NKD1 protein
could relieve its inhibitory effect on the Wnt pathway,
and activate it by up-regulating Dishevelled-1 in NSCLC.
Figure 6 NKD1 knockdown enhanced the invasive ability of lung cancer cells, while these could be ablated by anti-Dishevelled-1
antibody. Matrigel invasion assay showed that the normal group had fewer cells invading into the lower surface of the transwell filter than the
group transfected with NKD1 siRNA in LTEP (A) and LK (B) lines (P < 0.05). In contrast, When DVL-1 specific antibody incubated with NKD1 siRNA
in LTEP (A) and LK (B) lines, the invasive cell number was significantly reduced(P < 0.05).
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Additional file 1: Figure S1. The expression of NKD1 protein in lung
tissues and cell lines with NKD1 antibody II. (A). Compared with
normal lung tissue (N1-N3), NKD1 protein expression was significantly
decreased in lung cancer tissues (T1-T3) (P < 0.05). (B). NKD1 protein
expression in BE1 and LH7 cells was significantly lower than that in HBE
cells, a normal human bronchial epithelial cell line (P < 0.05).
Abbreviations
NKD1: Naked1; Dvl: Dishevelled; NSCLC: non-small cell lung cancer; MMP-7:
matrix metallopeptidase 7.
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